Cargando…
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Nanotechnology has been actively integrated as drug carriers over the last few years to treat various cancers. The main hurdle in the clinical management of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the researchers...
Autores principales: | Edis, Zehra, Wang, Junli, Waqas, Muhammad Khurram, Ijaz, Muhammad, Ijaz, Munazza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898224/ https://www.ncbi.nlm.nih.gov/pubmed/33628022 http://dx.doi.org/10.2147/IJN.S289443 |
Ejemplares similares
-
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Publicado: (2021) -
Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature
por: Alotaibi, Badriyah Shadid, et al.
Publicado: (2021) -
Nanocarriers for anticancer drugs: Challenges and perspectives
por: Alqosaibi, Amany I.
Publicado: (2022) -
Carboxylated Graphene Oxide as a Nanocarrier for Drug Delivery of Quercetin as an Effective Anticancer Agent
por: Yaghoubi, Fatemeh, et al.
Publicado: (2022) -
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
por: Sabit, Hussein, et al.
Publicado: (2022)